Mutz Christopher

ANI Pharmaceuticals, Inc. · HEAD OF RARE DISEASE

Mutz Christopher is listed in filings as HEAD OF RARE DISEASE at ANI Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 13, 2026, including sale activity. Recent filings connect the profile to ANI Pharmaceuticals, Inc. (ANIP). The current snapshot covers public activity from Nov 18, 2024 to Mar 13, 2026. Reported amounts are shown as $226.5K to $245.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
ANI Pharmaceuticals, Inc.ANIP$227k3.2k sharesSellMar 13, 2026$71.64$81.76